Illumina (ILMN) Jumps 24.8% on Earnings Beat

We recently published 10 Firms Dominating the Market; 5 at All-Time Highs. Illumina, Inc. (NASDAQ:ILMN) is one of the best-performing stocks on Friday.

Illumina rallied for a second day on Friday, climbing 24.78 percent to close at $123.54 apiece after beating its earnings guidance in the third quarter of the year and projecting a lower revenue decline in the full fiscal 2025 period.

In an updated report, Illumina, Inc. (NASDAQ:ILMN) saw net income fall by 79 percent to $150 million from $705 million previously, as revenues ended flat at $1.08 billion.

“Illumina team delivered Q325 results that exceeded the high-end of our guidance range for revenue and earnings, driven by revenue acceleration in clinical, our largest market segment,” said CEO Jacob Thaysen.

Illumina (ILMN) Jumps 24.8% on Earnings Beat

RAJ CREATIONZS / shutterstock.com

“During the quarter, we returned to growth ex-China and are executing on our strategic pillars that support our long-range financial targets,” he added.

For fiscal year 2025, Illumina, Inc. (NASDAQ:ILMN) now expects revenues to decline by only 0.5 percent to 1.5 percent year-on-year, a revision of the upper end range of 2.5 percent previously.

Illumina, Inc. (NASDAQ:ILMN) is one of the leading genomics companies that engages in providing DNA sequencing and array-based technologies for life sciences, oncology, and reproductive health, among others.

While we acknowledge the risk and potential of ILMN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ILMN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.